Jr. Ortlepp et al., A chymase gene variant is associated with atherosclerosis in venous coronary artery bypass grafts, CORON ART D, 12(6), 2001, pp. 493-497
Background Angiotensin II is known to stimulate proliferation of fibroblast
s and smooth muscle cells and enhance the atherosclerotic process in native
coronary arteries. The impact of genetic polymorphisms of the renin-angiot
ensin-aldosterone system on coronary bypass graft degeneration is unknown.
Methods We examined polymorphisms of four genes (AGTR1, CYP11B2, ACE, CMA)
in 101 patients who had follow-up coronary angiography due to symptoms 88 /- 52 months after coronary artery bypass graft surgery. Bypass degeneratio
n was determined with quantitative coronary angiography and an adjusted Gen
sini score.
Results Homozygosity for the G allele of the CMA-1905 polymorphism was asso
ciated with a higher degree of bypass degeneration (Bypass Gensini score CM
A AA 21.4 +/- 39; AG 24.2 +/- 39.8; GG 27.8 +/- 42.3; NS-time adjusted Gens
ini bypass scores CMA AA 0.25 +/- 0.68, AG 0.57 +/- 1.82; GG 3.25 +/- 13.2;
P=0.005). No association could be detected for the AGTR1, CYP11B2 or ACE p
olymorphism.
Conclusion The CMA allele G is a genetic risk factor for atherosclerosis in
venous coronary artery bypass grafts. Its importance has to be shown in fu
rther studies. Other polymorphisms of the renin-angiotensin-aldosterone sys
tem do not seem to play a role in bypass degeneration. Coron Artery Dis 12:
493-497 (C) 2001 Lippincott Williams & Wilkins.